Dr Shahid A Khan

Publications


Journals

  • Khan SA; Emadossadaty S; Ladep NG; Thomas HC; Elliott P; Taylor-Robinson SD; Toledano MB. (Apr 2012). Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?. J Hepatol. 56:848-854. DOI.
  • Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; et alTaylor-Robinson SD; Edwards RJ; Khan SA. (1 Sep 2011). Elevated Levels of Neutrophil Gelatinase-Associated Lipocalin in Bile From Patients With Malignant Pancreatobiliary Disease. AMERICAN JOURNAL OF GASTROENTEROLOGY. 106:1711-1717. Author weblink DOI.
  • Wadsworth CA; Dixon PH; Wong JH; Chapman MH; McKay SC; Sharif A; Spalding DR; Pereira SP; et alThomas HC; Taylor-Robinson SD; Whittaker J; Williamson C; Khan SA. (2011). Genetic factors in the pathogenesis of cholangiocarcinoma. Dig Dis. 29:93-97. DOI.
  • Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; et alTaylor-Robinson SD; Edwards RJ; Khan SA. (Sep 2011). Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease. Am J Gastroenterol. 106:1711-1717. DOI.
  • Hashim Abdalla MS; Taylor-Robinson SD; Sharif AW; Williams HR; Crossey MM; Badra GA; Thillainayagam AV; Bansi DS; et alThomas HC; Waked IA; Khan SA. (Jun 2011). Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma. HPB (Oxford). 13:385-390. DOI.
  • Shariff MI; Gomaa AI; Cox IJ; Patel M; Williams HR; Crossey MM; Thillainayagam AV; Thomas HC; et alWaked I; Khan SA; Taylor-Robinson SD. (1 Apr 2011). Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study. J Proteome Res. 10:1828-1836. DOI.
  • Patel M; Shariff MI; Ladep NG; Thillainayagam AV; Thomas HC; Khan SA; Taylor-Robinson SD. (Apr 2012). Hepatocellular carcinoma: diagnostics and screening. J Eval Clin Pract. 18:335-342. DOI.
  • Sharif AW; Williams HR; Lampejo T; Khan SA; Bansi DS; Westaby D; Thillainayagam AV; Thomas HC; et alCox IJ; Taylor-Robinson SD. (Aug 2010). Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy. HPB (Oxford). 12:396-402. DOI.
  • Shariff MI; Ladep NG; Cox IJ; Williams HR; Okeke E; Malu A; Thillainayagam AV; Crossey MM; et alKhan SA; Thomas HC; Taylor-Robinson SD. (5 Feb 2010). Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population. J Proteome Res. 9:1096-1103. DOI.
  • Tanwar S; Khan SA; Grover VP; Gwilt C; Smith B; Brown A. (28 Nov 2009). Liver transplantation for hepatocellular carcinoma. World J Gastroenterol. 15:5511-5516.
  • Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD. (Aug 2009). Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol. 3:353-367. DOI.
  • Mandeville KL; Krabshuis J; Ladep NG; Mulder CJJ; Quigley EMM; Khan SA. (21 Jun 2009). Gastroenterology in developing countries: Issues and advances. WORLD JOURNAL OF GASTROENTEROLOGY. 15:2839-2854. Author weblink DOI.
  • Khan SA; Thomas HC; Davidson BR; Taylor-Robinson SD. (20 May 2006). Cholangiocarcinoma (vol 366, pg 1303, 2005). LANCET. 367:1656-1656. Author weblink.
  • Adenugba A; Khan SA; Taylor-Robinson SD; Cox IJ; Toledano MB; Thillainayagam AV; Bansi DS; Thomas HC; et alGibson RW; Beck AJ. (Aug 2009). Polychlorinated biphenyls in bile of patients with biliary tract cancer. Chemosphere. 76:841-846. DOI.
  • Ariff B; Lloyd CR; Khan S; Shariff M; Thillainayagam AV; Bansi DS; Khan SA; Taylor-Robinson SD; et alLim AK. (21 Mar 2009). Imaging of liver cancer. World J Gastroenterol. 15:1289-1300.
  • Gomaa AI; Khan SA; Leen EL; Waked I; Taylor-Robinson SD. (21 Mar 2009). Diagnosis of hepatocellular carcinoma. World J Gastroenterol. 15:1301-1314.
  • Vavra P; Dostalik J; Zacharoulis D; Khorsandi SE; Khan SA; Habib NA. (Feb 2009). Endoscopic radiofrequency ablation in colorectal cancer: initial clinical results of a new bipolar radiofrequency ablation device. Dis Colon Rectum. 52:355-358. DOI.
  • Leen E; Kumar S; Khan SA; Low G; Ong KO; Tait P; Averkiou M. (21 Jan 2009). Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors. World J Gastroenterol. 15:289-299.
  • Kabunga P; Khan SA; Jackson P; Caplan M; Bendig J; Lim GA. (2004). Percutaneous endoscopic gastrostomies are reservoirs of microbiological contamination during nutritional treatment. Clinical Nutrition. 23:1471-1472.
  • Khan SA. (2002). Research samples are hard to obtain these days. British Medical Jornal. 325:429-429.
  • Khan SA; Taylor-Robinson SD. (2005). What if it’s acute cholangitis?. Drug and Therapeutics Bulletin. 43:62-64.
  • Khan SA; Toledano MB; Taylor-Robinson SD. (2008). Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 10:77-82. DOI.
  • Gomaa AI; Khan SA; Toledano MB; Waked I; Taylor-Robinson SD. (21 Jul 2008). Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. WORLD JOURNAL OF GASTROENTEROLOGY. 14:4300-4308. Author weblink DOI.
  • Pai M; Zacharoulis D; Milicevic MN; Helmy S; Jiao LR; Levicar N; Tait P; Scott M; et alMarley SB; Jestice K; Glibetic M; Bansi D; Khan SA; Kyriakou D; Rountas C; Thillainayagam A; Nicholls JP; Jensen S; Apperley JF; Gordon MY; Habib NA. (Aug 2008). Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol. 103:1952-1958. DOI.
  • Khan SA; Miras A; Pelling M; Taylor-Robinson SD. (1 Dec 2007). Cholangiocarcinoma and its management. GUT. 56:1755-1756. Author weblink DOI.
  • Matull W-R; Khan SA; Pereira SP. (7 Mar 2007). Re: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on incidence of intra- and extrahepatic cholangiocarcinorna in the United States. JOURNAL OF THE NATIONAL CANCER INSTITUTE. 99:407-407. Author weblink DOI.
  • Khan SA; Shah N; Williams R; Jalan R. (May 2006). Acute liver failure: a review. Clin Liver Dis. 10:239-viii. DOI.
  • Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine NR; Thomas HC. (May 2006). Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma. Int J Oncol. 28:1269-1277.
  • Khan SA; Taylor-Robinson SD; Toledano MB; Arora S; Hargreaves S; Beck A; Elliott P; Thomas HC. (1 Apr 2000). Increase in mortality rates for intrahepatic cholangiocarcinoma in England & Wales 1968-1996. GUT. 46:A74-A74. Author weblink.
  • Khan SA; Taylor-Robinson SD; Toledano M; Elliott P; Beck A; Thomas HC. (1 Jan 2000). Increase in mortality rates for intrahepatic cholangiocarcinoma in England & Wales 1968-1996. JOURNAL OF HEPATOLOGY. 32:117-117. Author weblink DOI.
  • Khan SA; Taylor-Robinson SD; Toledano MB; Beck A; Elliott P; Thomas HC. (1 Oct 2000). Comparison of trends in mortality rates rates for primary liver tumours worldwide 1979-1997. HEPATOLOGY. 32:228A-228A. Author weblink.
  • Khan SA; Taylor-Robinson SD; Toledano MB; Elliott P; Thomas HC. (1 Mar 2001). Worldwide trends in mortality rates for hepatobiliary and pancreatic tumours, 1979-1997. GUT. 48:A103-A103. Author weblink.
  • Khan SA; Carmichael PL; Taylor-Robinson SD; Habib N; Thomas HC. (1 Apr 2002). Evidence of an environmental cause for the rise in cholangiocarcinoma. GUT. 50:A54-A54. Author weblink.
  • Khan SA; Davidson BR; Goldin R; Pereira SP; Rosenberg WMC; Taylor-Robinson SD; Thillainayagam AV; Thomas HC; et alThursz MR; Wasan H. (1 Nov 2002). Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. GUT. 51:1-9. Author weblink.
  • Khan SA; Beck A; Carmichael PL; Taylor-Robinson SD. (1 Jan 2003). Unfriendly chemicals in pancreatic cancer - Invited commentary. PANCREATOLOGY. 3:7-8. Author weblink.
  • Khan SA; Taylor-Robinson SD; Toledano MB; Beck A; Elliott P; Thomas HC. (Dec 2002). Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 37:806-813.
  • Khan SA; Carmichael PL; Taylor-Robinson SD; Habib N; Thomas HC. (Apr 2003). DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma. Gut. 52:586-591.
  • Khan SA; Sharif AW; Taylor-Robinson SD. (May 2004). Photodynamic therapy significantly improves survival outcomes in people with non-resectable cholangiocarcinoma. Cancer Treat Rev. 30:315-318. DOI.
  • Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD. (Apr 2005). In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Liver Int. 25:273-281. DOI.
  • Khan SA; Cox IJ; Thillainayagam AV; Bansi DS; Thomas HC; Taylor-Robinson SD. (Jul 2005). Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. Eur J Gastroenterol Hepatol. 17:733-738.
  • Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD. (Aug 2005). p53 Mutations in human cholangiocarcinoma: a review. Liver Int. 25:704-716. DOI.
  • Khan SA; Thomas HC; Davidson BR; Taylor-Robinson SD. (8 Oct 2005). Cholangiocarcinoma. Lancet. 366:1303-1314. DOI.
  • Khan SA; Davidson BR; Goldin R; Pereira SP; Rosenberg WM; Taylor-Robinson SD; Thillainayagam AV; Thomas HC; et alThursz MR; Wasan H; British Society of Gastroenterology. (Nov 2002). Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 51 Suppl 6:VI1-VI9.

Chapters in books

  • Khan SA; Toledano MB; Ahmed M; Zabron AA; Taylor-Robinson SD. Liver Cancer: The view from the United Kingdom. In Clinical Dilemmas in Primary Liver Cancer. Williams R (ed); Taylor-Robinson SD (ed). Wiley (17 Jan 2012).
  • Sharif AW; Khan SA; Lindley CM; Lampejo TL; Goldin RJ; Cox IJ; Taylor-Robinson SD. Cholangiocarcinoma. In Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases. 596-607. Mahtab (ed). Elsevier India (1 Jan 2009).
  • Lim AK; Khan SA; Cox IJ; Taylor-Robinson SD. Nuclear magnetic resonance spectroscopy of in the study of human liver. In Nuclear magnetic resonance spectroscopy in the study of neoplastic tissue. 295-311. Tosi R (ed); Tugnoli V (ed). Nova Science, Hauppauge, New York (1 Jan 2005).
  • Sharif AW; Khan SA; Lindley CM; Lampejo TM; Goldin RD; Cox IJ; Taylor-Robinson SD. Cholangiocarcinoma. In Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases. 596-607. Al-Mahtab M (ed); Rahman S (ed). Elsevier, Noida (2009).
  • Khan SA; Goldin RD; Sharif A; Habib N. Histopathology and Molecular Pathogenesis of Biliary Tract Cancer. In Biliary Tract and Gallbladder Cancer: Diagnosis & Therapy. 1. Thomas CR (ed); Jr (ed); Fuller CD (ed). Demos Medical Publishing, USA (2008).
  • Lim AK; Khan SA; Cox IJ; Taylor-Robinson SD. Nuclear magnetic resonance spectroscopy of in the study of human liver. In Nuclear Magnetic Resonance Spectroscopy in the Study of Neoplastic Tissue. 1:295-311. Tosi R (ed); Tugnoli V (ed). Nova Science, Hauppauge, New York (2005).
  • Khan SA; Negus R. Oesophagogastroduodensocopy. In Hospital Surgery. 1. Aziz O (ed); Paraskeva PA (ed); Purkayastha S (ed). Cambridge University Press, UK (2008).

Conferences

  • Wadsworth CA; Dixon PH; Zabron AA; Wong JH; Chapman MH; McKay SC; Sharif AW; Spalding DR; et alPereira SP; Wasan HS; Thomas HC; Taylor-Robinson SD; Whittaker JC; Williamson C; Khan SA. GENETIC VARIATION IN BILIARY TRANSPORTERS AS A SUSCEPTIBILITY FACTOR FOR CHOLANGIOCARCINOMA. 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), 2011. 54:S109-S109. ELSEVIER SCIENCE BV (1 Mar 2011). Author weblink.
  • Wadsworth CA; Dixon PH; Zabron AA; Wong JH; Chapman MH; McKay SC; Spalding DR; Pereira SP; et alWasan HS; Thomas HC; Taylor-Robinson SD; Whittaker JC; Williamson C; Khan SA. COMMON GENETIC VARIATION IN NATURAL KILLER CELL RECEPTOR PROTEIN G2D DOES NOT MODIFY SUSCEPTIBILITY TO SPORADIC CHOLANGIOCARCINOMA. 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), 2011. 54:S108-S109. ELSEVIER SCIENCE BV (1 Mar 2011). Author weblink.
  • Dixon PH; Wadsworth CA; Chambers J; Donnelly JC; Cooley SM; Kubitz R; Lammert F; Marschall H-U; et alGlantz A; Khan SA; Whittaker J; Geary M; Williamson C. DOES COMMON GENETIC VARIATION AROUND THE PREGNANE-X RECEPTOR INFLUENCE SUSCEPTIBILITY TO INTRAHEPATIC CHOLESTASIS OF PREGNANCY?. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), 4 Nov 2011 - 8 Nov 2011. 54:924A-924A. WILEY-BLACKWELL (1 Oct 2011). Author weblink.
  • Asgheddi M; Abdullah M; ODonoghue M; Campbell L; Lalvani A; Wickremasinghe M; Kon OM; Khan SA. PREVALENCE OF VIRAL HEPATITIS IN PATIENTS UNDERGOING ANTI-TUBERCULOSIS THERAPY IN WEST LONDON. 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 29 Oct 2010 - 2 Nov 2010. 52:685A-686A. WILEY-BLACKWELL (1 Oct 2010). Author weblink.
  • Dixon PH; Wadsworth CA; Chambers J; Donnelly J; Cooley SM; Jarvis S; Kubitz R; Lammert F; et alMarschall H-U; Glantz A; Khan SA; Whittaker J; Geary M; Williamson C. THE ROLE OF COMMON GENETIC VARIATION AROUND SIX CANDIDATE LOCI FOR SUSCEPTIBILITY TO INTRAHEPATIC CHOLESTASIS OF PREGNANCY. 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 29 Oct 2010 - 2 Nov 2010. 52:479A-479A. WILEY-BLACKWELL (1 Oct 2010). Author weblink.
  • Wadsworth CA; Dixon PH; Zabron AA; Wong JH; Chapman MH; McKay SC; Spalding DR; Pereira SP; et alWasan HS; Thomas HC; Taylor-Robinson SD; Whittaker JC; Williamson C; Khan SA. GENETIC VARIATION IN NATURAL KILLER CELL RECEPTOR PROTEIN G2D DOES NOT MODIFY SUSCEPTIBILITY TO SPORADIC CHOLANGIOCARCINOMA. Annual Meeting on British-Society-of-Gasenterology, 14 Mar 2011 - 17 Mar 2011. 60. B M J PUBLISHING GROUP (1 Apr 2011). DOI.
  • Zabron AA; Horneffer-Van der Sluis VM; Geirula M; Wadsworth CA; Laird F; Thillainayagam AV; Vlavianos P; Westaby D; et alTaylor-Robinson SD; Edwards RJ; Khan SA. PROTEOMIC ANALYSIS OF BILE IN BENIGN AND MALIGNANT PANCREATOBILIARY DISEASE. Annual General Meeting of the British-Society-of-Gastroenterology, 22 Mar 2010 - 25 Mar 2010. 59:A82-A83. B M J PUBLISHING GROUP (1 Apr 2010). DOI.
  • Khan SA; Emadossadaty S; Taylor-Robinson SD; Elliott P; Thomas HC; Toledano MB. MISCLASSIFICATION OF HILAR (KLATSKIN) CHOLANGIOCARCINOMAS: AN INVESTIGATION OF CODING PRACTICE IN THE UK. 45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 14 Apr 2010 - 18 Apr 2010. 52:S221-S221. ELSEVIER SCIENCE BV (1 Jan 2010). Author weblink.
  • Wadsworth CA; Young IR; Rea M; Ahmad MM; Khorsandi SE; Davidson B; Khan S; Taylor-Robinson SD; et alSyms RR. A CATHETER-MOUNTED MAGNETIC RESONANCE DETECTOR COIL FOR BILIARY IMAGING: FIRST EX VIVO HUMAN HEPATOBILIARY IMAGES. 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 30 Oct 2009 - 3 Nov 2009. 50:740A-741A. JOHN WILEY & SONS INC (1 Oct 2009). Author weblink.
  • Parviz N; Edwards RJ; Wasan HS; Taylor-Robinson SD; Toledano MB; Cox J; Khan S. PLASMA PROTEOMIC PROFILING OF PATIENTS WITH CHOLANGIOCARCINOMA. 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 31 Oct 2008 - 4 Nov 2008. 48:984A-985A. JOHN WILEY & SONS INC (1 Oct 2008). Author weblink.
  • Adenugba A; Khan SA; Taylor-Robinson SD; Cox IJ; Toledano MB; Thillainayagam AV; Bansi DS; Gibson RW; et alThomas HC; Beck AC. POLYCHLORINATED BIPHENYLS IN BILE OF PATIENTS WITH BILIARY TRACT CANCER. 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 22 Apr 2009 - 26 Apr 2009. 50:S188-S188. ELSEVIER SCIENCE BV (1 Jan 2009). Author weblink.
  • Wadsworth CA; Syms RRA; Khan SA; Dickinson RJ; Gedroyc WMW; Thursz MR; Ahmad MM; Awan SA; et alCaspersz W; Taylor-Robinson SD; Young IR. A CATHETER-MOUNTED MAGNETIC RESONANCE DETECTOR COIL FOR BILIARY IMAGING: FIRST IN VITRO BILIARY IMAGES. Annual Meeting of the British-Society-of-Gastroenterology, 23 Mar 2009 - 26 Mar 2009. 58:A147-A147. B M J PUBLISHING GROUP (1 Apr 2009). Author weblink.
  • Toledano MB; Mehtan A; Elliott P; Taylor-Robinson SD; Thomas HC; Khan SA. UPDATE OF INCIDENCE AND MORTALITY RATES AND REVIEW OF DIAGNOSTIC TRENDS FOR INTRAHEPATIC CHOLANGIOCARCINOMA AND SELECTED HEPATOBILIARY TUMOURS IN ENGLAND AND WALES. Annual Meeting of the British-Society-of-Gastroenterology, 23 Mar 2009 - 26 Mar 2009. 58:A67-A67. B M J PUBLISHING GROUP (1 Apr 2009). Author weblink.
  • Adenugba A; Khan SA; Taylor-Robinson SD; Cox I; Toledano MB; Thillainayagam AV; Bansi DS; Gibson RW; et alThomas HC; Beck AJ. POLYCHLORINATED BIPHENYLS IN BILE OF PATIENTS WITH BILIARY TRACT CANCER. Annual Meeting of the British-Society-of-Gastroenterology, 23 Mar 2009 - 26 Mar 2009. 58:A67-A67. B M J PUBLISHING GROUP (1 Apr 2009). Author weblink.
  • Nassim P; Edwards RJ; Wasan H; Cox I; Toledano MB; Taylor-Robinson SD; Khan SA. PLASMA PROTEOMIC PROFILING OF PATIENTS WITH CHOLANGIOCARCINOMA. Annual Meeting of the British-Society-of-Gastroenterology, 23 Mar 2009 - 26 Mar 2009. 58:A17-A17. B M J PUBLISHING GROUP (1 Apr 2009).
  • Khan SA; Cox IJ; Bansi D; Thillainayagam A; Thomas HC; Taylor-Robinson SD. Analysis of bile in patients with and without pancreaticobiliary malignancy by in vitro 31-phosphorus NMR spectroscopy. Annual meeting of the British-Society-of-Gastroenterology. 52:A92-A92. (Apr 2003).
  • Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine N; Thomas HC. Novel p53 mutations but lack of a mutational fingerprint in human intrahepatic cholangiocarcinoma. Annual meeting of the British-Society-of-Gastroenterology, 23 Mar 2003 - 26 Mar 2003. 52:A32-A32. BRITISH MED JOURNAL PUBL GROUP (1 Apr 2003). Author weblink.
  • Khan SA; Mandeville K; Toledano MB; Thomas HC; Taylor-Robinson SD. Update of mortality and incidence rates for intrahepatic cholangiocarcinoma and other hepatobiliary tumours in England and Wales. 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 13 Apr 2005 - 17 Apr 2005. 42:95-95. ELSEVIER SCIENCE BV (1 Apr 2005). Author weblink.

Reports

  • Abu-Amara M; Khan SA; Sarah F; Lim AG. An unusual cause of melaena in a Patient on Warfarin. CME Journal of Gastroenterology, Hepatology & Nutrition (2004). 81-82.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook